The Incubator Labs are expanding
The laboratories at Oslo Cancer Cluster Incubator are expanding to meet increasing demand from members.
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 279 entries.
The laboratories at Oslo Cancer Cluster Incubator are expanding to meet increasing demand from members.
Dr. Jon Amund Kyte at Oslo University Hospital aims to bring more and better clinical trials to Norway.
Targovax, one of the members of Oslo Cancer Cluster, has begun an expansion patient group in the clinical trial of a drug to treat skin cancer. The company Targovax is developing immune activators to target solid tumours that are difficult to treat. The drug in question, called ONCOS-102, is aimed at patients with malignant melanoma (skin […]
Vaccibody and Roche have started a new collaboration to investigate a drug combination for patients with advanced cervical cancer.
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.